Compare Cadila Healthcare with Piramal Enterprises - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs PIRAMAL ENTERPRISES - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE PIRAMAL ENTERPRISES CADILA HEALTHCARE/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 25.0 -48.8 - View Chart
P/BV x 4.4 1.6 266.3% View Chart
Dividend Yield % 0.8 1.4 56.0%  

Financials

 CADILA HEALTHCARE   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-20
PIRAMAL ENTERPRISES
Mar-19
CADILA HEALTHCARE/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs3523,303 10.7%   
Low Rs2071,797 11.5%   
Sales per share (Unadj.) Rs139.2716.5 19.4%  
Earnings per share (Unadj.) Rs11.879.7 14.8%  
Cash flow per share (Unadj.) Rs18.6107.9 17.2%  
Dividends per share (Unadj.) Rs3.5028.00 12.5%  
Dividend yield (eoy) %1.31.1 114.1%  
Book value per share (Unadj.) Rs101.41,477.5 6.9%  
Shares outstanding (eoy) m1,023.74184.45 555.0%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x2.03.6 56.4%   
Avg P/E ratio x23.732.0 74.2%  
P/CF ratio (eoy) x15.023.6 63.7%  
Price / Book Value ratio x2.81.7 159.8%  
Dividend payout %29.835.1 84.7%   
Avg Mkt Cap Rs m286,033470,292 60.8%   
No. of employees `00013.47.8 171.4%   
Total wages/salary Rs m24,14522,504 107.3%   
Avg. sales/employee Rs Th10,632.716,899.4 62.9%   
Avg. wages/employee Rs Th1,801.22,877.7 62.6%   
Avg. net profit/employee Rs Th898.51,879.9 47.8%   
INCOME DATA
Net Sales Rs m142,531132,153 107.9%  
Other income Rs m1,1393,128 36.4%   
Total revenues Rs m143,670135,281 106.2%   
Gross profit Rs m24,19866,290 36.5%  
Depreciation Rs m6,9655,202 133.9%   
Interest Rs m3,41844,097 7.8%   
Profit before tax Rs m14,95420,119 74.3%   
Minority Interest Rs m2883,194 9.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,1988,611 37.1%   
Profit after tax Rs m12,04414,701 81.9%  
Gross profit margin %17.050.2 33.8%  
Effective tax rate %21.442.8 50.0%   
Net profit margin %8.511.1 76.0%  
BALANCE SHEET DATA
Current assets Rs m87,154122,742 71.0%   
Current liabilities Rs m82,694310,810 26.6%   
Net working cap to sales %3.1-142.3 -2.2%  
Current ratio x1.10.4 266.9%  
Inventory Days Days7123 309.7%  
Debtors Days Days9439 241.5%  
Net fixed assets Rs m133,236116,904 114.0%   
Share capital Rs m1,024369 277.6%   
"Free" reserves Rs m102,733272,161 37.7%   
Net worth Rs m103,757272,530 38.1%   
Long term debt Rs m32,146270,196 11.9%   
Total assets Rs m236,866856,261 27.7%  
Interest coverage x5.41.5 369.1%   
Debt to equity ratio x0.31.0 31.2%  
Sales to assets ratio x0.60.2 389.9%   
Return on assets %6.56.9 95.1%  
Return on equity %11.65.4 215.2%  
Return on capital %13.712.4 110.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m52,75215,200 347.0%   
Fx outflow Rs m14,5044,889 296.7%   
Net fx Rs m38,24810,312 370.9%   
CASH FLOW
From Operations Rs m25,054-115,975 -21.6%  
From Investments Rs m-10,123-8,265 122.5%  
From Financial Activity Rs m-10,942107,525 -10.2%  
Net Cashflow Rs m3,989-16,650 -24.0%  

Share Holding

Indian Promoters % 74.8 52.9 141.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 4.0 207.5%  
FIIs % 5.9 26.6 22.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 16.5 66.7%  
Shareholders   44,069 93,274 47.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   GLENMARK PHARMA  J.B.CHEMICALS  FDC  ASTRAZENECA PHARMA  STRIDES PHARMA SCIENCE  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Share Markets Open Higher; JSW Steel & Tata Steel Top Gainers(09:30 am)

Asian share markets edged higher today as investors shrugged off concerns that stocks may have rallied too far too fast in the past year.

Related Views on News

PIRAMAL ENTERPRISES at 52 Week High; BSE 500 Index Up 1.0% (Market Updates)

Mar 3, 2021 | Updated on Mar 3, 2021

PIRAMAL ENTERPRISES share price has hit a 52-week high. It is presently trading at Rs 1,969. BSE 500 Index is up by 0.9% at 20,109. Within the BSE 500, PIRAMAL ENTERPRISES (up 2.6%) and IFCI (up 11.8%) are among the top gainers, while top losers are IRCON INTERNATIONAL and MMTC.

CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY21); Net Profit Up 22.1% (Quarterly Result Update)

Aug 25, 2020 | Updated on Aug 25, 2020

For the quarter ended June 2020, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 22.1% YoY). Sales on the other hand came in at Rs 29 bn (down 16.2% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Mar 3, 2021 11:52 AM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS